Article Details

Analysts See $-1.06 EPS for Paratek Pharmaceuticals, Inc. (PRTK)

Retrieved on: 2019-10-14 13:29:16

Tags for this article:

Click the tags to see associated articles and topics

Analysts See $-1.06 EPS for Paratek Pharmaceuticals, Inc. (PRTK). View article details on hiswai:

Excerpt

<div><b>Baupost Group</b> Inc Limited Company Ma holds 0.09% of its portfolio in Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) for 2.39M shares.</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up